Meet Anatara

Anatara Lifesciences is developing evidence based solutions for gastrointestinal health in humans and animals.

Introducing Anatara’s technology

GaRP is the working title for Anatara’s evidence-based complementary medicine. One which contains a special form of bromelain, an enzyme found in pineapple stems, along with other safe and recognised components. These GaRP ingredients, when combined and coated, have a positive impact on the lining of your digestive system. They also promote a healthy balance in the gut’s ecosystem and its chemical byproducts, while allowing specific parts of your digestive tract to absorb these components effectively. GaRP’s diverse effects make it adaptable for addressing different health concerns, and we are currently conducting human trials to further understand its benefits.

Human Applications

Anatara is developing proprietary formulations for gastrointestinal health.


Introducing Gastrointestinal ReProgramming (GaRP), a microbiome-targeted complementary medicine.

Anatara’s GaRP product is a microbiome-targeted multi-component complementary medicine that has been designed to address the primary underlying factors associated with gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).


Our formulations are being positioned as adjuncts to existing therapies, and will not be replacing current prescription medications. Over the last 20 years the use of complementary medicine as adjuncts to prescription drugs has increased significantly.

Animal Applications

Non-antibiotic products for pigs and poultry.


Anatara developed Detach® for the control of scour (diarrhoea) in pigs which was approved the Australian Pesticides and Veterinary Medicines Authority (APVMA) for this application.


Detach® has been shown to reduce post-weaning diarrhoea and provide similar protection to antimicrobial agents including zinc oxide as well as reduce antimicrobial resistance However, Detach® requires labour and effort to deliver the compound by drenching. BONIFF is a revised formulation that is applied to dry feed for piglets after weaning, reducing labour input and simplifying the entire process. Anatara successfully completed a piglet challenge trial which concluded that BONIFF could be considered as a replacement for a non-physiological level of zinc oxide with commercial levels of additives in a semi-moist extruded creep piglet diet.


Anatara has also developed ANR-pf, a proprietary enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method on-farm even when stock illness is a concern. Anatara successfully completed a poultry challenge trial “Efficacy of ANR-pf on the performance of broilers subject to subclinical and necrotic enteritis challenges”.

Get to know us

Meet the team

Backed by a well credentialed Board and Management team, and world-leading scientific collaborators, Anatara is uniquely positioned to fulfill a significant unmet medical need in gut health in humans.

Board of Directors

Dr David Brookes

Executive Chair

Nicholas Haslam

Non-Executive Director

John Michailidis

Executive Director

Our Team

Simon Erskine

Chief Development Officer

John Michailidis

Chief Operator Officer

Stephen Denaro

Company Secretary

Michael West

Chief Scientific Officer

Agency Partners & Advisors

The Big Creative

Communications, Media, Branding & Digital Communications

Contact Information

Candour Advisory

Investor Relations & Corporate Advisory

Contact Information

Clinical & Scientific Advisory Board

Professor Peter Gibson

Advisory Board Member

Professor Rebecca Burgell

Advisory Board Member

Professor Jakob Begun

Advisory Board Member

Dr Jeremy Rosenbaum

Advisory Board Member

Professor Paul Rolan

Advisory Board Member

Professor Simon Keely

Advisory Board Member

Dr Tracey Brown

Advisory Board Member

Evidence-based treatments for gastrointestinal health
Want to stay up to date with our trials and latest news?
Sign up here

    All rights reserved © Anatara Lifesciences 2024